The expression level of platelet-derived growth factor receptor (PDGFR)B in ALK+ ALCL was found to be positively correlated with the cytotoxicity of PDGFR inhibitors, which may be effective in the treatment of PDGFRB+ ALK+ ALCL. The gene discussed is PDGFRB; the disease is anaplastic large cell lymphoma.